report-image

Bortezomib Market Analysis by Types (1mg, 3.5mg, 5mg, Others), by Applications (Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Others), by Route of Administration (Oral, Intravenous, Subcutaneous, Others), by Dosage (Tablet, Injection, Powder, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by End-Users (Clinic, Hospital, Others) and by Region: Global Forecast, 2024 - 2034

  • PUBLISHED ON
  • 2024-04-30
  • NO OF PAGES
  • 191
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Bortezomib market is predicted to develop at a compound annual growth rate (CAGR) of 4.68% from 2024 to 2034, when it is projected to reach USD 38.53 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 24.39 Billion in 2024.


 

SOURCE: We Market Research

A drug called boratezomib is used to treat cancer, more especially blood cancers such as multiple myeloma and mantle cell lymphoma. It is a member of the class of medications known as proteasome inhibitors, which function by preventing the action of proteasomes, which are biological entities that degrade proteins. Bortezomib suppresses proteasomes, which upsets the regular functions of cancer cells and eventually causes them to die. This medication is given intravenously and is frequently included in chemotherapy treatments for some types of cancer. When combined with other medications, boratezomib has demonstrated a significant efficacy in improving patient outcomes for patients with mantle cell lymphoma and multiple myeloma and slowing the course of their malignancy.

The rising prevalence of blood cancers such multiple myeloma and mantle cell lymphoma, along with improvements in cancer treatment, are driving demand for boretinomib in the global market. Increased access to Bortezomib is made possible by expanding the healthcare infrastructure and improving awareness and diagnostics. Its market potential is increased by approvals for new indications. Furthermore, increased demand is a result of the growing geriatric population, especially in wealthy countries. Innovation in Bortezomib-based treatments is further fueled by ongoing investments in research and development. All of these factors support the expansion and widespread use of bortezomib globally. 

Market Scope

Report Attributes

Description

Market Size in 2024

USD 24.39 Billion

Market Forecast in 2034

USD 38.53Billion

CAGR % 2024-2034

4.68%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2034

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

by Types, by Applications, by Route of Administration, by Dosage, by Distribution Channel, by End-Users and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Bortezomib Industry: Dynamics & Restrains


Market opportunity:


 We Market Research: Bortezomib Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.


Bortezomib Segmentation

Market- By Applications Analysis

By Applications, the Bortezomib Market is Categories into Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Others. The Multiple Myeloma segment accounts for the largest share of around 56% in 2024.


The drug's effectiveness in treating this particular cancer type is the main factor propelling the expansion of the multiple myeloma sector in the worldwide bortezomib market. Bortezomib's use in this application has been fueled by its proteasome inhibition mechanism, which has shown considerable clinical benefits in multiple myeloma patients, including increased overall survival and disease control.

The following segments are part of an in-depth analysis of the global Bortezomib market:

Market Segments

 

By  Types

·         1mg

·         3.5mg

·         5mg

·         Others

By  Route of Administration

·         Oral

·         Intravenous

·         Subcutaneous

·         Others

By  Dosage

·         Tablet

·         Injection

·         Powder

·         Others

By Distribution Channel

·         Hospital Pharmacy

·         Retail Pharmacy

·         Online Pharmacy

By End-Users

·         Clinic

·         Hospital

·         Others

 

Bortezomib Industry: Regional Analysis

North America Market Forecast

North America dominate the Bortezomib Market with the highest revenue generating market with share of more than 47%. The North American market for bortezomib is bolstered by a robust healthcare infrastructure, a high incidence of multiple myeloma, and favorable payment guidelines. Major industry participants make R&D investments, which stimulate innovation and market growth. The increasing use of bortezomib as a cancer treatment in this area is attributed to ongoing clinical trials and strong patient awareness.


Europe Market Statistics

Europe's bortezomib market is propelled by increasing cancer incidence, government initiatives promoting cancer care, and advanced medical technologies. The region's aging population adds to the demand for cancer treatments, including bortezomib. Accessible healthcare and rising awareness about cancer contribute to market growth, attracting investments in oncology research and development.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Bortezomib market during the forecast period. The Asia-Pacific region's bortezomib market is expanding as a result of enhanced healthcare facilities, increased disposable income, and greater public knowledge of cancer detection and treatment options. Multiple myeloma and lymphoma are becoming more common in the area, which is driving up demand for cutting-edge cancer treatments like bortezomib. Market expansion is further propelled by investments in the healthcare sector and the growing pharmaceutical industry.

Key Market Players

The Bortezomib Market is dominated by a few large companies, such as

·         Novartis International AG (Switzerland)

·         Bristol Myers Squibb (U.S.)

·         Teva Pharmaceutical Industries Ltd. (Israel)

·         Takeda Pharmaceutical Company Limited (Japan)

·         Pfizer Inc. (U.S.)

·         Johnson & Johnson (U.S.)

·         Mylan Pharmaceuticals Inc. (U.S.)

·         Sun Pharmaceutical Industries Ltd. (India)

·         Others

1.      Global Bortezomib Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Bortezomib Market Scope and Market Estimation

1.2.1. Global Bortezomib Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2024 - 2034)

1.2.2. Global Bortezomib Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Bortezomib Market

1.3.2. Technology of Global Bortezomib Market

1.3.3. Route of Administration  of Global Bortezomib Market

1.3.4. Region of Global Bortezomib Market

2.      Executive Summary

2.1.    Global Bortezomib Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Bortezomib Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Bortezomib Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Bortezomib Market Estimates & Forecast Trend Analysis, by TYPE

4.1.    Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 - 2034

4.1.1. 1mg

4.1.2. 3.5mg

4.1.3. 5mg

4.1.4. Others

5.      Global Bortezomib Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 - 2034

5.1.1. Lymphoma

5.1.2. Mantle Cell Lymphoma

5.1.3. Multiple Myeloma

5.1.4. Others

6.      Global Bortezomib Market Estimates & Forecast Trend Analysis, by Route of Administration

6.1.    Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration , 2019 - 2034

6.1.1. Oral

6.1.2. Intravenous

6.1.3. Subcutaneous

6.1.4. Others

7.      Global Bortezomib Market Estimates & Forecast Trend Analysis, by DOSAGE

7.1.    Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2019 - 2034

7.1.1. Tablet

7.1.2. Injection

7.1.3. Powder

7.1.4. Others

8.      Global Bortezomib Market Estimates & Forecast Trend Analysis, by DISTRIBUTION CHANNEL

8.1.    Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2019 - 2034

8.1.1. Hospital Pharmacy

8.1.2. Retail Pharmacy

8.1.3. Online Pharmacy

9.      Global Bortezomib Market Estimates & Forecast Trend Analysis, by END-USERS

9.1.    Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2019 - 2034

9.1.1. Clinic

9.1.2. Hospital

9.1.3. Others

10.  Global Bortezomib Market Estimates & Forecast Trend Analysis, by Region

10.1.                     Global Bortezomib Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 - 2034

10.1.1.    North America

10.1.2.    Europe

10.1.3.    Asia Pacific

10.1.4.    Middle East & Africa

10.1.5.    South America

11.  North America Bortezomib Market: Estimates & Forecast Trend Analysis

11.1.      North America Bortezomib Market Assessments & Key Findings

11.1.1.    North America Bortezomib Market Introduction

11.1.2.    North America Bortezomib Market Size Estimates and Forecast (US$ Million) (2019 - 2034)

11.1.2.1.    By TYPE

11.1.2.2.    By Application

11.1.2.3.    By Route of Administration

11.1.2.4.    By DOSAGE

11.1.2.5.    By DISTRIBUTION CHANNEL

11.1.2.6.    By END-USERS

11.1.2.7.    By Country

11.1.2.7.1. The U.S.

11.1.2.7.2. Canada

11.1.2.7.3. Mexico

12.  Europe Bortezomib Market: Estimates & Forecast Trend Analysis

12.1.  Europe Bortezomib Market Assessments & Key Findings

12.1.1.   Europe Bortezomib Market Introduction

12.1.2.   Europe Bortezomib Market Size Estimates and Forecast (US$ Million) (2019 - 2034)

12.1.2.1.    By TYPE

12.1.2.2.    By Application

12.1.2.3.    By Route of Administration

12.1.2.4.    By DOSAGE

12.1.2.5.    By DISTRIBUTION CHANNEL

12.1.2.6.    By END-USERS

12.1.2.7.    By Country

12.1.2.7.1. Germany

12.1.2.7.2. U.K.

12.1.2.7.3. France

12.1.2.7.4. Italy

12.1.2.7.5. Spain

12.1.2.7.6. Russia

12.1.2.7.7. Rest of Europe

13.  Asia Pacific Bortezomib Market: Estimates & Forecast Trend Analysis

13.1.  Asia Pacific Market Assessments & Key Findings

13.1.1.    Asia Pacific Bortezomib Market Introduction

13.1.2.    Asia Pacific Bortezomib Market Size Estimates and Forecast (US$ Million) (2019 - 2034)

13.1.2.1.    By TYPE

13.1.2.2.    By Application

13.1.2.3.    By Route of Administration

13.1.2.4.    By DOSAGE

13.1.2.5.    By DISTRIBUTION CHANNEL

13.1.2.6.    By END-USERS

13.1.2.7.    By Country

13.1.2.7.1. China

13.1.2.7.2. Japan

13.1.2.7.3. India

13.1.2.7.4. Australia

13.1.2.7.5. South Korea

13.1.2.7.6. ASEAN

13.1.2.7.7. Rest of Asia Pacific

14.  Middle East & Africa Bortezomib Market: Estimates & Forecast Trend Analysis

14.1.  Middle East & Africa Market Assessments & Key Findings

14.1.1.   Middle East & Africa Bortezomib Market Introduction

14.1.2.   Middle East & Africa Bortezomib Market Size Estimates and Forecast (US$ Million) (2019 - 2034)

14.1.2.1.    By TYPE

14.1.2.2.    By Application

14.1.2.3.    By Route of Administration

14.1.2.4.    By DOSAGE

14.1.2.5.    By DISTRIBUTION CHANNEL

14.1.2.6.    By END-USERS

14.1.2.7.    By Country

14.1.2.7.1. U.A.E.

14.1.2.7.2. Saudi Arabia

14.1.2.7.3. Egypt

14.1.2.7.4. South Africa

14.1.2.7.5. Rest of Middle East & Africa

15.  South America Bortezomib Market: Estimates & Forecast Trend Analysis

15.1.  South America Market Assessments & Key Findings

15.1.1.   South America Bortezomib Market Introduction

15.1.2.   South America Bortezomib Market Size Estimates and Forecast (US$ Million) (2019 - 2034)

15.1.2.1.    By TYPE

15.1.2.2.    By Application

15.1.2.3.    By Route of Administration

15.1.2.4.    By DOSAGE

15.1.2.5.    By DISTRIBUTION CHANNEL

15.1.2.6.    By END-USERS

15.1.2.7.    By Country

15.1.2.7.1. Brazil

15.1.2.7.2. Argentina

15.1.2.7.3. Colombia

15.1.2.7.4. Rest of South America

16.  Competition Landscape

16.1.  Global Bortezomib Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

16.2.  Global Bortezomib Market Competition White Space Analysis, By Route of Administration

16.3.  Global Bortezomib Market Competition Heat Map Analysis, By Route of Administration

16.4.  Global Bortezomib Market Concentration & Company Market Shares (%) Analysis, 2023

17.  Company Profiles

17.1.                     Novartis International AG (Switzerland)

17.1.1.    Company Overview & Key Stats

17.1.2.    Financial Performance & KPIs

17.1.3.    Product Portfolio

17.1.4.    Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

17.2.      Bristol Myers Squibb (U.S.)

17.3.      Teva Pharmaceutical Industries Ltd. (Israel)

17.4.      Takeda Pharmaceutical Company Limited (Japan)

17.5.      Pfizer Inc. (U.S.)

17.6.      Johnson & Johnson (U.S.)

17.7.      Mylan Pharmaceuticals Inc. (U.S.)

17.8.      Sun Pharmaceutical Industries Ltd. (India)

17.9.      Others

18.  Research Methodology

18.1.  External Transportations / Databases

18.2.  Internal Proprietary Database

18.3.  Primary Research

18.4.  Secondary Research

18.5.  Assumptions

18.6.  Limitations

18.7.  Report FAQs

19.  Research Findings & Conclusion

 

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Bortezomib Market in 2024?

Bortezomib Market was valued at USD 24.39 Billion in 2024.

What is the growth rate for the Bortezomib Market?

Bortezomib Market size will increase at approximate CAGR of 4.68% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Bortezomib Market Are Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Mylan Pharmaceuticals Inc. (U.S.), Novartis International AG (Switzerland), Bristol Myers Squibb (U.S.), Teva Pharmaceutical Industries Ltd. (Israel).

Which region dominates the Bortezomib Market?

North America dominates the market with an active share of 47%.

Sample Request Customized Requirement Speak to Analyst Check Discount
CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

Buy Now
  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

Buy Now
  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

Buy Now
  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI